Navigation Links
Cearna Introduces Product Designed to Reduce Patient’s Recovery Time From Facial Plastic Surgery
Date:3/19/2013

Chicago, IL (PRWEB) March 19, 2013

Cearna, Inc. has officially launched, OcuMend™, a new product designed to decrease a patient’s recovery time by five to seven days from blepharoplasty (eyelid) and Rhinoplasty (nose) facial plastic surgery. OcuMend is an easy-to-use, healing gel pad that reduces bruising, pain and swelling allowing patients to get back to work and their life faster. OcuMend was well received when beta tested nationwide in 2012 with plastic surgeons reporting that 89 percent of their patients recovered faster, and of these, 63 percent recovered five to seven days faster.

“The use of OcuMend has decreased the amount of bruising and swelling in the post-operative period. This has led to a noticeable improvement in the recovery of my cosmetic blepharoplasty patients,” shares Dr. William P. Mack, a board certified surgeon who specializes in oculoplastic surgery and facial cosmetic surgery in Tampa, FL.

A third-party, anonymous survey* commissioned by Cearna confirmed that length of recovery time is important to patients having facial plastic surgery. 75 percent of respondents said that given the choice between two surgeons, they would choose the one who can get them back to work faster without bruising. Additionally, 80 percent said they are willing to pay a premium for a product that could reduce their recovery time. In the beta test, 96 percent of patients who used OcuMend responded “likely to very likely” to recommend OcuMend to a friend.

“The use of OcuMend in our practice sets us apart by delivering results that we cannot obtain with any other product,” states Dr. Jack Zamora, an oculo-facial plastic surgeon and principal practitioner with Cosmetic Surgery Consultants in Denver, CO. “Patients want to recover over a long weekend instead of recovery taking more than a week. OcuMend allows our patients to return to their lives sooner.”

A natural product, OcuMend is 50 times stronger than any Arnica plastic surgery product and is the only plastic surgery product containing Ledum which is indicated for periorbital surgery. Easily integrated into post-op patient protocol, OcuMend healing gel pads decrease the need for patients to lie down and apply ice allowing movement during recovery, and increases patient compliance. This breakthrough treatment is available to patients exclusively through physicians’ offices.

Cearna offers a four-surgery, sample program for qualified surgeons to see the difference OcuMend makes with their own patients. Surgeons can request to participate in the program by emailing info(at)cearna(dot)com.

Founded in 2010 by Dr. Josephine Polich, Cearna, Inc. changes the way patients recover from plastic surgery by getting them back to their work and life faster. The company is engaged in the research, development and commercialization of surgery and trauma recovery products with a mission is to help people recover faster by reducing bruising, swelling and pain. For more information about Cearna and its products, visit http://www.cearna.com or call 630-740-4580.

*For survey information, email info(at)cearna(dot)com.

Read the full story at http://www.prweb.com/releases/Plastic_Surgery_Recovery/Cosmetic_Facial_Surgery/prweb10524249.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Rigaku Introduces New Instruments at Pittcon 2013
2. GIN Introduces Advanced Robotics and Dispensing Technology at BVS La Jolla Biotech Day
3. FMC BioPolymer Introduces Its New Portfolio of Nature-Based Nutritional Solutions
4. Percival Scientific, Inc. Introduces an Affordable LED Lighting System for the Research Industry
5. Palomar Medical Center in San Diego County Introduces New Wrist-Worn Wireless Patient Vital Signs Device
6. Vista College Introduces Its New Medical Laboratory Technician Diploma Program At El Paso Campus
7. GLM Displays Introduces New Banner Stand – 10’ Tall “Giant Mosquito”
8. Rigaku introduces the world’s most comprehensive biological SAXS system for the home lab
9. ARAMARK Introduces Worlds First Reusable Validated Sterile Goggle That Remains Clear When Irradiated
10. Inflamax Research Introduces Electronic Patient Data Acquisition Tablet™ (ePDAT)™ for Real-Time PRO Data Collection
11. Superlift Introduces The ToolMan Manlift and On-site Contractor Tool
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017  ArmaGen, Inc., a privately held biotechnology ... severe neurological disorders, today reported preliminary evidence of ... company,s investigational therapy for the treatment of Hurler ... I, or MPS I). The initial results from ... today at the 13 th annual WORLD ...
(Date:2/16/2017)... PALM BEACH, Florida , February 16, 2017 ... vastly improving with the infusion of innovative telemedicine ... patient monitoring services that are experiencing a boom ... evolve with the advancement of technologies, services and ... Technologies Inc. (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, ...
(Date:2/16/2017)... ... February 16, 2017 , ... ... Dr. Kingsley Chin, professor and Harvard trained surgeon, completed the procedure on Monday, ... on a 55-year-old practicing female physician suffering from degenerative disc disease with radiculomyelopathy, ...
(Date:2/16/2017)... ... February 16, 2017 , ... ... Inc. has further extended its industry leading Biochemistry Services specifically targeting the ... cGMP techniques and methods for the biochemical and biosimilar characterization , ...
Breaking Biology Technology:
(Date:2/7/2017)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that the latest release ... flexible and award winning eClinical solution, is now available ... is a proven Software-as-a-Service (SaaS) clinical research technology platform ... also delivers an entire suite of eClinical tools to ...
(Date:2/6/2017)... 6, 2017 According to Acuity Market ... border authorities to continue to embrace biometric and ... 2143 Automated Border Control (ABC) eGates and 1436 ... more than 163 ports of entry across the ... achieving a combined CAGR of 37%. APC Kiosks ...
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
Breaking Biology News(10 mins):